FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B

The single-dose medicine "represents important progress" as the first-ever gene therapy for the rare disorder, the FDA said.
Read more: https://www.cbsnews.com/news/fda-approves-hemgenix-most-expensive-drug-hemophilia-b/?source=Snapzu